wada banned bpc-157 WADA's Stance on PRP and Peptides BPC-157: Experimental Peptide Creates Risk

Phase 2/3 trial of structurally distinct prodrug fosgonimeton (Athira ATH-1017) missed primary endpoint in 2023 Product Specifications Format: capsules Strength: 10 mg per capsule Count: 30 capsules per bottle Purity: 98% (HPLC verified) Container: sealed amber bottle Certificate of Analysis: lot-specific COA available See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information

Dosing protocols, treatment regimens, and administration instructions are out of scope and are not provided in any form

The Morris water maze task, a spatial memory test, involved an 8-day acquisition phase and a Day 9 probe trial

Nutritional/dietary supplements, including vitamins and minerals, are not well regulated and may cause a positive drug test

Consequently, it remains one of the most compelling compounds in modern neuroendocrine and metabolic research